Pura Vida Investments

The firm sources through a combination of primary scientific literature review, attending key medical conferences, and maintaining direct relationships with sell-side healthcare research desks. Given its concentration in binary events like FDA decision dates and clinical-trial readouts, the sourcing process is calendar-driven — the universe is public, but the depth of single-name due diligence is what separates Pura Vida from generalist peer funds.

Pura Vida deploys across both public and private healthcare exposures, though the weighting has historically favored liquid public equities due to the firm's event-driven positioning around regulatory catalysts. Private participation tends to be opportunistic, often in crossover rounds where companies approach an IPO or a pivotal data readout.

Pura Vida maintains offices in New York City and North Palm Beach, Florida. The New York presence anchors the firm in the US hedge fund capital with access to sell-side resources and capital introductions, while the Palm Beach office is a common satellite for senior investment professionals in the industry. Beyond this geographic footprint, the firm has not disclosed subsidiary or adjacent vehicles such as a philanthropic foundation.